National Cancer Control Policy
    • home
    • Preventable risk factors
      • Tobacco control
      • Obesity
      • UV radiation
      • Alcohol and cancer
      • Occupational cancers
    • Screening and immunisation
      • Principles of screening
      • Cancer vaccines
      • Breast cancer
      • Bowel cancer
      • Cervical cancer
      • Liver cancer
      • Prostate cancer
    • Cancer care
      • Drug access and affordability
    • View
    • View source
    • History
    • What links here
    • Related changes
    • Special pages
    • Permanent link
    • Page information
    • Browse properties

    Citation:FUTURE I/II Study Group, Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, et al 2010

    From National Cancer Control Policy
    Jump to:navigation, search

    FUTURE I/II Study Group, Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, et al. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ 2010 Jul 20;341:c3493 Available from: http://www.ncbi.nlm.nih.gov/pubmed/20647284.


    Critical appraisals

    • Assign a critical appraisal


    Cited by

    1. Prevention
    Retrieved from "https://wiki.cancer.org.au/policy_mw/index.php?title=Citation:FUTURE_I/II_Study_Group,_Dillner_J,_Kjaer_SK,_Wheeler_CM,_Sigurdsson_K,_Iversen_OE,_et_al_2010&oldid=4443"
    Cancer Council would like to acknowledge the traditional custodians of the land on which we live and work. We would also like to pay respect to the elders past and present and extend that respect to all other Aboriginal people.